Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Making Medicines Affordable
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Health, United States
Health, United States, 2008
Author:
Publisher:
ISBN:
Category : Health status indicators
Languages : en
Pages : 616
Book Description
Publisher:
ISBN:
Category : Health status indicators
Languages : en
Pages : 616
Book Description
Health, United States, 2006 with Chartbook on Trends in the Health of Americans
Author:
Publisher: National Center for Health Statistics
ISBN: 9780160773297
Category : Medical
Languages : en
Pages : 530
Book Description
Publisher: National Center for Health Statistics
ISBN: 9780160773297
Category : Medical
Languages : en
Pages : 530
Book Description
Survey of Current Business
Author:
Publisher:
ISBN:
Category : Commercial statistics
Languages : en
Pages : 1268
Book Description
Publisher:
ISBN:
Category : Commercial statistics
Languages : en
Pages : 1268
Book Description
Health, United States, 2010 with Special Feature on Death and Dying
Author:
Publisher: Office of the Secretary, Historical Offi
ISBN: 9780160879425
Category : Medical
Languages : en
Pages : 572
Book Description
34rd report on the health status of the Nation. Presents national trends in health statistics. Each report includes an executive summary, highlights, a chartbook, trend tables, extensive appendixes, and an index.
Publisher: Office of the Secretary, Historical Offi
ISBN: 9780160879425
Category : Medical
Languages : en
Pages : 572
Book Description
34rd report on the health status of the Nation. Presents national trends in health statistics. Each report includes an executive summary, highlights, a chartbook, trend tables, extensive appendixes, and an index.
The SAGE Encyclopedia of Business Ethics and Society
Author: Robert W. Kolb
Publisher: SAGE Publications
ISBN: 148338151X
Category : Business & Economics
Languages : en
Pages : 4074
Book Description
Spans the relationships among business, ethics, and society by including numerous entries that feature broad coverage of corporate social responsibility, the obligation of companies to various stakeholder groups, the contribution of business to society and culture, and the relationship between organizations and the quality of the environment.
Publisher: SAGE Publications
ISBN: 148338151X
Category : Business & Economics
Languages : en
Pages : 4074
Book Description
Spans the relationships among business, ethics, and society by including numerous entries that feature broad coverage of corporate social responsibility, the obligation of companies to various stakeholder groups, the contribution of business to society and culture, and the relationship between organizations and the quality of the environment.
New Dimensions in Women's Health
Author: Linda Lewis Alexander
Publisher: Jones & Bartlett Learning
ISBN: 1284178412
Category : Health & Fitness
Languages : en
Pages : 504
Book Description
Revised and update to keep pace with changes in the field, the best-selling New Dimensions in Women's Health, Eighth Edition provides a modern look at the health of women of all cultures, races, ethnicities, socioeconomic backgrounds, and sexual orientations. Written for undergraduate students within health education, nursing, and women's studies programs, the text provides readers with the critical information needed optimize their well-being, avoid illness and injury, and support their overall health. The authors took great care to provide in-depth coverage of important aspects of women's health and to examine the contributing epidemiological, historical, psychosocial, cultural, ethical, legal, political, and economic influences.
Publisher: Jones & Bartlett Learning
ISBN: 1284178412
Category : Health & Fitness
Languages : en
Pages : 504
Book Description
Revised and update to keep pace with changes in the field, the best-selling New Dimensions in Women's Health, Eighth Edition provides a modern look at the health of women of all cultures, races, ethnicities, socioeconomic backgrounds, and sexual orientations. Written for undergraduate students within health education, nursing, and women's studies programs, the text provides readers with the critical information needed optimize their well-being, avoid illness and injury, and support their overall health. The authors took great care to provide in-depth coverage of important aspects of women's health and to examine the contributing epidemiological, historical, psychosocial, cultural, ethical, legal, political, and economic influences.
Basics of the U.S. Health Care System
Author: Nancy J. Niles
Publisher: Jones & Bartlett Learning
ISBN: 0763769843
Category : Business & Economics
Languages : en
Pages : 366
Book Description
The health care industry currently provides over 13 million jobs with a projected 27 percent increase over the next decade the largest increase of any other industry. Given these trends, a basic understanding of the U.S. health care system is important to students across many disciplines including business, law, health administration, pre-medicine, nursing, allied health, public health, and more. This combination textbook and activity workbook gives students a fundamental understanding of the basic concepts of the U.S. healthcare system. Written with the undergraduate in mind, Basics of the U.S. Health Care System uses simple, reader-friendly language and features hands-on exercises that engage the student in active learning. Each chapter offers a vocabulary crossword puzzle, a vocabulary exercise, real life exercises, and Internet exercises.
Publisher: Jones & Bartlett Learning
ISBN: 0763769843
Category : Business & Economics
Languages : en
Pages : 366
Book Description
The health care industry currently provides over 13 million jobs with a projected 27 percent increase over the next decade the largest increase of any other industry. Given these trends, a basic understanding of the U.S. health care system is important to students across many disciplines including business, law, health administration, pre-medicine, nursing, allied health, public health, and more. This combination textbook and activity workbook gives students a fundamental understanding of the basic concepts of the U.S. healthcare system. Written with the undergraduate in mind, Basics of the U.S. Health Care System uses simple, reader-friendly language and features hands-on exercises that engage the student in active learning. Each chapter offers a vocabulary crossword puzzle, a vocabulary exercise, real life exercises, and Internet exercises.
People with colorectal cancer in SEER-Medicare
Author: Sujha Subramanian
Publisher: RTI Press
ISBN:
Category : Medical
Languages : en
Pages : 14
Book Description
Limited information exists about enrollment in Part D prescription coverage by Medicare beneficiaries with cancer. Part D coverage may increase access to medicines. This study evaluated patterns of Part D uptake and costs and assessed the effects of coverage on hospitalizations and emergency department (ED) use among people with colorectal cancer (CRC). We analyzed Surveillance, Epidemiology, and End Results (SEER)–Medicare linked data on fee-for-service (FFS) Medicare beneficiaries with at least 36 months of follow-up who were diagnosed with CRC at any point from January 2007 through December 2010, and a matched cohort of beneficiaries without cancer. Dual (Medicare/Medicaid) enrollees were excluded because they are automatically enrolled in Part D. Among beneficiaries with CRC (n = 12,774), 39 percent had complete Part D coverage, defined as coverage in the diagnosis year and 2 subsequent years; the rate was 38 percent in the matched comparison cohort (P = .119). Among those with complete Part D coverage, there was no significant difference in annual prescription drug costs between people with CRC ($3,157, 95% confidence interval [CI]: $3,098–$3,216) and without ($3,113, 95% CI: $3,054–$3,172). Among people with CRC, odds of ED use ranged from unchanged to marginally higher for those with no or partial Part D coverage, (adjusted odds ratio: 1.09, 95% CI: 1.00–1.18), compared with those with complete Part D coverage. Lack of continuous Part D coverage was associated with more ED use among Medicare FFS beneficiaries with CRC in 2007–2013. Among people with Part D coverage, prescription drug costs varied little between those with CRC and matched beneficiaries without cancer.
Publisher: RTI Press
ISBN:
Category : Medical
Languages : en
Pages : 14
Book Description
Limited information exists about enrollment in Part D prescription coverage by Medicare beneficiaries with cancer. Part D coverage may increase access to medicines. This study evaluated patterns of Part D uptake and costs and assessed the effects of coverage on hospitalizations and emergency department (ED) use among people with colorectal cancer (CRC). We analyzed Surveillance, Epidemiology, and End Results (SEER)–Medicare linked data on fee-for-service (FFS) Medicare beneficiaries with at least 36 months of follow-up who were diagnosed with CRC at any point from January 2007 through December 2010, and a matched cohort of beneficiaries without cancer. Dual (Medicare/Medicaid) enrollees were excluded because they are automatically enrolled in Part D. Among beneficiaries with CRC (n = 12,774), 39 percent had complete Part D coverage, defined as coverage in the diagnosis year and 2 subsequent years; the rate was 38 percent in the matched comparison cohort (P = .119). Among those with complete Part D coverage, there was no significant difference in annual prescription drug costs between people with CRC ($3,157, 95% confidence interval [CI]: $3,098–$3,216) and without ($3,113, 95% CI: $3,054–$3,172). Among people with CRC, odds of ED use ranged from unchanged to marginally higher for those with no or partial Part D coverage, (adjusted odds ratio: 1.09, 95% CI: 1.00–1.18), compared with those with complete Part D coverage. Lack of continuous Part D coverage was associated with more ED use among Medicare FFS beneficiaries with CRC in 2007–2013. Among people with Part D coverage, prescription drug costs varied little between those with CRC and matched beneficiaries without cancer.